Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site
Attention Deficit/Hyperactivity Disorder (ADHD) Stimulant Medications
Highlights:
  • According to SAMHSA's Drug Abuse Warning Network (DAWN) for 2004, an estimated 7,873 drug-related emergency department visits involved methylphenidate or amphetamine-dextroamphetamine, two medications used to treat attention deficit/ hyperactivity disorder (ADHD).
  • The most frequent reason for these ADHD stimulant medication related visits was nonmedical use (48%), followed by adverse reactions associated with medical use (34%), accidental ingestion (10%), and suicide attempts (8%).
  • The rates of DAWN emergency department visits involving methylphenidate or amphetamine-dextroamphetamine for patients aged 12 to 17 were higher than the rates for patients aged 18 or older.
  • About 68% of the DAWN emergency department visits involving nonmedical use of methylphenidate or amphetamine-dextroamphetamine also involved another substance (such as alcohol, an illicit drug, or a pharmaceutical).

Data on other specific drugs

Other topics

Other OAS publications and services

This Short Report, The New DAWN Report:  Emergency Department Visits Involving ADHD Stimulant Medications, is based on the Drug Abuse Warning Network (DAWN), the primary source of national data on drug related emergency department visits.  DAWN is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  

This is the page footer.

This page has been accessed 132341 times since 9/22/06.

This page was last updated on September 22, 2006. 

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

This is a line.

   Site Map | Contact Us | AccessibilityPrivacy PolicyFreedom of Information Act
 Disclaimer | Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* PDF formatted files require that Adobe Acrobat ReaderĀ® program is installed on your computer. Click here to download this FREE software now from Adobe.